Home/Filings/4/0001209191-18-046092
4//SEC Filing

Mason Brad 4

Accession 0001209191-18-046092

CIK 0000884624other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 6:45 PM ET

Size

11.7 KB

Accession

0001209191-18-046092

Insider Transaction Report

Form 4
Period: 2018-08-07
Mason Brad
President and CEO
Transactions
  • Sale

    Common Stock

    2018-08-07$53.02/sh1,400$74,225151,141 total
  • Sale

    Common Stock

    2018-08-07$51.41/sh300$15,423152,541 total
  • Sale

    Common Stock

    2018-08-07$53.95/sh500$26,977150,641 total
  • Sale

    Common Stock

    2018-08-07$55.14/sh300$16,543150,341 total
Footnotes (5)
  • [F1]The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.14 to $51.79, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  • [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.46 to $53.37, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
  • [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.63 to $54.43, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
  • [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.12 to $55.16, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.

Issuer

Orthofix Medical Inc.

CIK 0000884624

Entity typeother

Related Parties

1
  • filerCIK 0001572153

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 6:45 PM ET
Size
11.7 KB